Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: zax who wrote (155)	3/14/2000 4:07:00 PM
From: Carter Patterson	Read Replies (1) \| Respond to of 746

>>CRA cannot incorporate its use of government funded basic human genome research into its database and then in turn patent the derivative work. Uncle sam and us taxpayers just wouldn't stand for that. Furthermore, in my opinion no company has the right to exclusively own blueprints to the human genome. This will undoubtedly be tested in court sooner or later. I don't disagree. The blue print of Human Genome is not patentable any more than the atomic makeup of water. So what is the President trying to give away today if its already been given away? My perception is that he wants to expand on the US Patent Office statement that says you can't patent the blueprint of DNA. I doubt he'll be successful, but he'll hurt this market and industry why he tries to do it.